Jonathan Drachman

2016 - Seattle Genetics

In 2016, Jonathan Drachman earned a total compensation of $3.8M as Chief Medical Officer at Seattle Genetics, a 60% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$294,600
Option Awards$1,534,003
Salary$510,167
Stock Awards$1,433,700
Other$12,405
Total$3,784,875

Drachman received $1.5M in option awards, accounting for 41% of the total pay in 2016.

Drachman also received $294.6K in non-equity incentive plan, $510.2K in salary, $1.4M in stock awards and $12.4K in other compensation.

Rankings

In 2016, Jonathan Drachman's compensation ranked 2,407th out of 14,075 executives tracked by ExecPay. In other words, Drachman earned more than 82.9% of executives.

ClassificationRankingPercentile
All
2,407
out of 14,075
83rd
Division
Manufacturing
832
out of 5,486
85th
Major group
Chemicals And Allied Products
243
out of 1,900
87th
Industry group
Drugs
177
out of 1,543
89th
Industry
Biological Products, Except Diagnostic Substances
36
out of 287
88th
Source: SEC filing on April 5, 2017.

Drachman's colleagues

We found six more compensation records of executives who worked with Jonathan Drachman at Seattle Genetics in 2016.

2016

Clay Siegall

Seattle Genetics

Chief Executive Officer

2016

Eric Dobmeier

Seattle Genetics

Chief Operating Officer

2016

Vaughn Himes

Seattle Genetics

Chief Technical Officer

2016

Darren Cline

Seattle Genetics

Former Executive Vice President, Commercial

2016

Todd Simpson

Seattle Genetics

Chief Financial Officer

2016

Jean Liu

Seattle Genetics

General Counsel

News

You may also like